Managing CV Risk in Indonesia: How well are we doing and where can we improve?
Lecture held by Professor Anwar Santoso, MD, University of Indonesia, Jakarta, Indonesia, during the CV Risk Master Class held on October 22, 2016 in Yogyakarta, Indonesia
Educational information
The overall educational objectives of the Cardiovascular Master Class were:
- To review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk in Indonesia
- To review new data on the pathophysiology of coronary artery disease and stroke and its relevance to treatment strategies and outcomes
- To understand the medical need for intensive lipid and hypertension management in patients at high CV risk, such as DM and metabolic syndrome.
- To understand the pharmacologic and clinical rationale for various treatment options in the patients with increased CV risk and integrate scientific evidence from key clinical trials into clinical practice
- Develop a consensus on practical guidelines for day-to-day management of high risk patients
Accreditation
This Master Class was endorsed and accredited by the Indonesian Cardiology Association
Disclosures
Dr Anwar Santoso, MD is Consultant Cardiologist at National Cardiovascular Center Harapan Kita Hospital, and lecturer at Dept. Cardiology – Vascular Medicine; Faculty of Medicine – Universitas lndonesia
Funding
The CV Risk master class was funded by an unrestricted educational grant provided by Pfizer
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: